Soligenix (SNGX) Retained Earnings (2010 - 2026)
Soligenix's (SNGX) quarterly Retained Earnings came in at $45789.0 in Q1 2026, down 99.98% YoY from $240.8 million in Q1 2025, and little changed on a QoQ basis from $45789.0 in Q4 2025.
Soligenix (SNGX) Retained Earnings (2010 - 2026) Analysis & Trends
Soligenix (SNGX) has 17 years of Retained Earnings data on file, last reported at $45789.0 in Q1 2026.
- Quarterly Retained Earnings fell 99.98% year-over-year to $45789.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45789.0 (down 99.98% YoY) and the FY2025 annual result came in at $45789.0, down 99.98% from the prior year.
- Retained Earnings was little changed at $45789.0 in Q1 2026, from $45789.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $249.7 million in Q3 2025 to a low of -$231.0 million in Q3 2024.
- A 5-year average of $30.9 million and a median of $45789.0 in 2025 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 3839194.51% in 2024, down 949945.32% in 2024.
- Tracing SNGX's Retained Earnings over 5 years: stood at -$219.6 million in 2022, then surged by 100.01% to $22243.0 in 2023, then jumped by 1070081.72% to $238.0 million in 2024, then plunged by 99.98% to $45789.0 in 2025, then changed by 0.0% to $45789.0 in 2026.
- The last three Retained Earnings figures came in at $45789.0 (Q1 2026), $45789.0 (Q4 2025), and $249.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - | 256.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 256.44 Mn |
| Mar 31, 2026 | 45,789.00 |
| Dec 31, 2025 | 45,789.00 |
| Sep 30, 2025 | 249.70 Mn |
| Jun 30, 2025 | 45,789.00 |
| Mar 31, 2025 | 240.77 Mn |
| Dec 31, 2024 | 238.04 Mn |
| Sep 30, 2024 | -230.98 Mn |
| Jun 30, 2024 | 232.70 Mn |
| Mar 31, 2024 | 228.35 Mn |
| Dec 31, 2023 | 22,243.00 |
| Sep 30, 2023 | 24,318.00 |
| Jun 30, 2023 | 6,061.00 |
| Mar 31, 2023 | -220.61 Mn |
| Dec 31, 2022 | -219.56 Mn |
| Sep 30, 2022 | 25,472.00 |
| Jun 30, 2022 | 216.65 Mn |
| Mar 31, 2022 | -210.11 Mn |
| Dec 31, 2021 | 41,942.00 |
| Sep 30, 2021 | 216.02 Mn |